Monod Bio, Inc.
Biotechnology company · Seattle, Washington, United States
Monod Bio, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2020. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $290,066 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2022.
Monod Bio at a glance
What does Monod Bio do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $290,066 in total (2024). NIH funding came from the National Institute of General Medical Sciences, National Center for Advancing Translational Sciences.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $24.2 million sold (2022).
Frequently asked questions about Monod Bio
Where is Monod Bio headquartered?
Monod Bio, Inc. is headquartered in Seattle, Washington, United States.
What does Monod Bio do?
Monod Bio, Inc. is a biotechnology company.
When was Monod Bio founded?
The earliest incorporation on record for Monod Bio, Inc. is in 2020, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences